 | Monter d'un niveau |
Akinsoji, T., Dragojlovic, N., Darviot, C., Meunier, M., & Lynd, L. D. (2024). PP53 Potential Cost-Effectiveness And Innovation Headroom Of A More Accurate Companion Diagnostic For PD-L1 In Non-Small-Cell Lung Cancer. [Affiche]. International Journal of Technology Assessment in Health Care, 40(S1), S76-S76. Présentée à Health Technology Assessment international Annual Meeting (HTAi 2024), Seville, Spain. Lien externe
Darviot, C., Gosselin, B., Martin, F., Patskovsky, S., Jabin, I., Bruylants, G., Trudel, D., & Meunier, M. (2024). Multiplexed immunolabelling of cancer using bioconjugated plasmonic gold–silver alloy nanoparticles. Nanoscale Advances, 2024, 9 pages. Disponible
